Improve health and reduce the risk of lung cancer. Visit getchecked.eu/reduce-your-ri… to learn more. This campaign is endorsed by: European Lung Foundation ERS European Patients' Forum #getcheckedeurope #lungcancereurope #lcsm #lcam

Our ALK+ lung cancer community is grateful to all those who devote themselves to cancer research & patient care. Advances in #lungcancer #research bring not only better therapies but hope. It's why Dr Christine Lovly believes #MoreResearchMoreLife #LCAM

Jan loves quilting & spending time at the lake. Since last year, she's living w/ incurable #ALKPositive #lungcancer. Jan knows that life-saving lung cancer treatments are made by relentless research. Please fund research: alkpositive.kindful.com. #MoreResearchMoreLife #LCAM

ALK+ #lungcancer: How do we achieve deeper, longer responses? Why aren’t all tumour cells killed w/ treatment? What drives treatment resistance? Whatever the question, Dr Jeff Yang MD FACS believes the best answers come from working together. #MoreResearchMoreLife #LCAM #LCSM

Our LuCE team works hard to develop reports that tackle relevant challenges in the lung cancer community. You can read all our previous reports at lungcancereurope.eu/reports-and-po… #lungcancereurope #lungcancerawarenessmonth #lcam #lcsm #lungcancer #beatlungcancer

Meet Florence. Loves spending time with family. Living with w/ stage 4, #ALKPositive #lungcancer for 3 yrs. Thanks to research, meds inhibit Florence's cancer. But people w ALK develop resistance to their meds. Fund life➡️ alkpositive.kindful.com. #MoreResearchMoreLife #LCAM

#LungCancerAwarenessMonth may have ended yesterday, but our problems have not. Not for people like Amanda who is living with #stage4 #ALKPositive lung cancer since 2016. We believe #MoreResearchMoreLife. Every donation can help: alkpositive.kindful.com #LCAM #LCSM

#Lungcancer is not a single disease! At the Belgian Symposium on Molecular Biology, we discussed emergent drivers (EGFR ex20, MET, RET, KRAS, NTRK, BRAF, HER2) & some new (NRG1) 💥 Pls do a comprehensive #molecular analysis to #all non-sq adv #NSCLC at Dx!! Belgian Society of Medical Oncology Institut Jules Bordet Instituut

Congrats to this year’s recipients of the ALK Positive/LUNGevity Foundation Research Awards: Trevor Bivona, Bivona Lab; Roberto Chiarle @Chiarlelab & @AngelQinMD.👏👏 We’re proud of the $1.75m raised by the ALK Positive Inc patient community for these grants! prnewswire.com/news-releases/…

Find out more by reading the 7th LuCE report, available at lungcancereurope.eu/reports-and-po… Please share this with your friends and family to help spread awareness for lung cancer ❤️ #lungcancerawareness #biomarkertest #lungcancersupport #cancerawareness #lungcancer

Pour rappeler que l’expertise infirmière mérite d'être mieux valorisée et mise à profit, nous lançons une nouvelle campagne de communication : les infirmières et infirmiers sont plus que des bras. oiiq.org/les-infirmiere… #expertiseinfirmière

Treating lung cancer patients as individuals is vital, giving them the support and specialised treatment they need and deserve. 💙 #lungcancereurope #specialisedtreatment #lungcancermutations #lungcancertreatment #lungcancer #cancertreatment #lungcancersupport

🎥Watch the full webinar on our YouTube channel: youtu.be/PpeuNcn4uK8 Please share this post to help support more people who are facing lung cancer. 💙 #lungcancer #lungcancerpathway #lungcancerrehab #lungcancerprehab #lungcancereffects #lungcancereurope #lungcancersupport

The increasing complexity and bureaucracy of clinical research is a threat to progress and is only getting worse. Great article Annals of Oncology by Jose Luis Perez-Gracia Teresa Amaral, MD, PhD and more ESMO - Eur. Oncology highlights some of the major issues. #StreamlineClinicalResearch annalsofoncology.org/article/S0923-…

If you've been diagnosed with lung cancer or are caring for someone with the disease, your voice matters. We invite you to share your experience in this anonymous survey on the financial repercussions of lung cancer on individuals and their families. surveymonkey.com/r/LuCESurvey20…

If you or your family has been impacted by lung cancer - please consider taking part in the Lung Cancer Europe survey on the financial impact of the disease. Please share. #lcsm #EU #Europe #LuCEcrew #IrishLungCancerCommunity

We're pleased to announce a groundbreaking research partnership with Lung Cancer Research Foundation to fund $2 million in ALK-positive lung cancer research over the next 3 years. This award will support research focused on ALK-positive non-small cell lung cancer (NSCLC). alkpositive.org/blog/2023/6/15…

16 years ago today, the very first article about non-small cell lung cancer (NSCLC) with an ALK-positive mutation was published in Nature by a team of doctors in Japan. To read the official abstract from Nature, click below: pubmed.ncbi.nlm.nih.gov/17625570/

📢 Program update: NVL-655 has received FDA breakthrough therapy designation (BTD)! This important milestone for our ALK program marks the second BTD granted to our pipeline this year. $NUVL #NSCLC investors.nuvalent.com/2024-05-16-Nuv…

At ASCO24 multiple interesting and probably practice changing clinical trials will be presented, my stellar colleagues and I will discuss the highlights and practical take aways. Join us!